Squarepoint Ops LLC Ionis Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 166,468 shares of IONS stock, worth $5.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

166,468

Previous 127,341 30.73%

Holding current value

$5.38 Million

Previous $5.1 Million 14.08%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$33.73 - $40.36 $1.32 Million - $1.58 Million	39,127 Added 30.73%	166,468 $5.82 Million
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $12.4 Million - $16 Million	-309,477 Reduced 70.85%	127,341 $5.1 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $11.2 Million - $14.7 Million	-308,355 Reduced 41.38%	436,818 $20.8 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $28.8 Million - $36.7 Million	685,969 Added 1158.65%	745,173 $32.3 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $373,370 - $444,276	-8,605 Reduced 12.69%	59,204 $3 Million
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $1.58 Million - $1.98 Million	-45,591 Reduced 40.2%	67,809 $2.78 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $2.27 Million - $2.79 Million	-67,607 Reduced 37.35%	113,400 $4.05 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $3.3 Million - $4.14 Million	88,953 Added 96.63%	181,007 $6.84 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.38 Million - $1.84 Million	-37,886 Reduced 29.16%	92,054 $4.07 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $3.52 Million - $4.77 Million	111,046 Added 587.73%	129,940 $4.81 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $1.27 Million - $1.57 Million	-42,446 Reduced 69.2%	18,894 $700,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $2.78 Million - $3.81 Million	-108,525 Reduced 63.89%	61,340 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $4.1 Million - $4.95 Million	122,120 Added 255.78%	169,865 $5.7 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $972,577 - $1.33 Million	28,158 Added 143.76%	47,745 $1.91 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $3.57 Million - $5.35 Million	-83,903 Reduced 81.07%	19,587 $881,000
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $1.58 Million - $2.1 Million	34,896 Added 50.87%	103,490 $5.85 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $2.74 Million - $3.63 Million	57,739 Added 531.91%	68,594 $3.26 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $6.43 Million - $8.38 Million	-137,289 Reduced 92.67%	10,855 $640,000
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $1.26 Million - $1.92 Million	30,272 Added 25.68%	148,144 $7 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $1.75 Million - $2.12 Million	-32,459 Reduced 21.59%	117,872 $7.12 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $684,328 - $836,002	-11,587 Reduced 7.16%	150,331 $9.01 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $2.59 Million - $3.6 Million	41,738 Added 34.73%	161,918 $10.4 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $5.79 Million - $8.88 Million	109,460 Added 1021.08%	120,180 $9.76 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $464,926 - $638,268	10,720 New	10,720 $580,000
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $4.35 Million - $5.43 Million	-98,617 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $4.11 Million - $5.26 Million	81,655 Added 481.4%	98,617 $4.96 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $772,788 - $1.01 Million	16,962	16,962 $860,000

Others Institutions Holding IONS

# of Institutions

412

Shares Held

140M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.59B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Ionis Pharmaceuticals Inc Transaction History